Soil testing for molecular amplification technologies is a challenge due to containing many inhibitors to the process. This white paper describes the Verne Bio’s team validation of our Hop Latent Viroid WE-Test protocol that is a multiplex qPCR assay based on our patent pending 4D-qPCR technology. We were able to develop and validate a high throughput protocol for quantification of Hop Latent Viroid
April 12, 2023 Read More
Developing and validating our 16-pathogen Cannabis Pathogen focus panel requires rigorous validation to ensure specificity and sensitivity. This white paper describes the Verne Bio’s team validation of our protocol that is a multiplex qPCR assay based on our patent pending 4D-qPCR technology.
April 12, 2023 Read More
Utilizing isothermal amplification principles, we are able to develop molecular-based testing that can be run on-site with limited training. This white paper describes the Verne Bio’s team validation of our protocol to detect hop latent viroid that utilizes our own patent pending isothermal amplification technology: layered isothermal amplification or LARIAT.
April 12, 2023 Read More
Dr. Nathan Johnson, Ph.D. is the President & CEO of Verne Bio. He has a hybrid of microbiology, molecular biology, and bioinformatics expertise across 15 years for food testing, oncology, immunology, stem cell biology, animal model development, and plant-related efforts. He has published peer-review scientific papers including in prestigious journals such as Nature, Cell, and Science, and held positions such as Dana Farber Cancer Institute, Harvard Medical School, Takeda, H3 Biomedicine, and Mouse and Rat Resource Centers. He holds a Ph.D. in Bioinformatics & Computational Biology, MS in Biomedical Sciences, and a BS in biology and minor in chemistry.
Mark has been practicing law since 2002 primarily focused on patent law, who is extremely successful at resolving many intellectual property disputes between patent/trademark/copyright owners and alleged infringers, either by litigation, mediation, arbitration, or settlement. In addition to being a lawyer, he also holds a BS degree in both Biology and Chemistry and an MS in Molecular Biology. His unique perspective has allowed him to obtain many patents and registered trademarks for his clients in areas as diverse as mechanical, electrical, software, business methods, biotechnology, computer systems, energy, and cooling system innovations. Mark has a special interest and expertise in biotechnology and bioinformatics areas of patent law.
Seth is currently working at Verne Bio full-time after recently completed his Bachelor's in Biology from Assumption University in Worcester, Massachusetts.
Mike has been a start-up CFO since 2013, both as a full-time employee and as a fractional consulting CFO, delivering GAAP-compliant financials, driving revenue growth, fundraising, negotiating contracts, budgeting/forecasting, managing cash, and ensuring compliance. He has over thirty years of executive leadership and consulting experience in assisting both large and small organizations through difficult realignments of their strategy, finances, and business processes. Mike’s expertise includes driving both top and bottom-line financial performance for all types of businesses, aligning business strategy, improving operations, as well as managing HR, Legal and Operations teams. Mike is also an expert in financial modeling and developing scenario-based financial forecasts. He began his career at Booz, Allen & Hamilton, successfully helping large Fortune 500 companies like Chevron, Mobil Oil, Apple, Fox, First Nationwide and Bechtel. While consulting at M Squared, he helped Cisco on a series of programs including incubating and growing a multi-billion dollar sales initiative. Mike received an MBA in finance, marketing, strategy, and entrepreneurship from the Kellogg School of Management at Northwestern, and a BA from Claremont McKenna College.
Yvonne oversees the company's social media platforms, customer service and creating high-quality visual and written content as Verne's Sales and Marketing Manager. She also analyzes customer engagements and utilize social media strategies in order to build trends for customer interactions. Apart from Social Media Management, she develops and strengthen the company's marketing opportunities and sales activities.
Andi is a computer scientist with 8+ years of interdisciplinary experience in bioinformatics of complex disease, computational genomics, biomedical data analytics, and database optimizations. Additionally, he has experience in machine learning, and statistical genetics. In particular, he has also developed computational methods, hardware-optimized algorithms to understand the evolution of animal and plant genomes on a large scale. In machine learning, Andi has worked on scalable inference methods for Support Vector Machine models to discriminate cancer from non-cancerous cell-lines irrespective of the tissue of origin. More recently, he created a framework to detect protein effectors in gram-negative bacteria across all six secretion systems without prior knowledge of bacterial secretion system(s) or cryptic secretion signals. Specialties: Comparative & Computational Genomics, Machine Learning, Biomedical Data Mining, Information visualization, High-Performance Computing, Theory of Computation, Programming/Script Languages, Unix, Mobile/Web Applications.
Jacob is a serial entrepreneur, family office advisor and investment professional with experience across a multitude of industries including agriculture/cannabis, animal health, automotive/mobility, aviation, healthcare, hospitality, commercial & residential real estate, energy, sustainability, residential solar, construction, retail, SaaS, security & defense, web3 and more. Lebo brings an international focus with deep experience in origination, DD, capital formation, valuations, strategy, international expansion, and financial reporting.
to receive updates and news on our products, events and promos!
